PKA and AMPK Signaling Pathways Differentially Regulate Luteal Steroidogenesis

Area of Science:

• Reproductive Endocrinology
• Molecular Endocrinology
• Cellular Metabolism

Background:

• Luteinizing hormone (LH) stimulates ovulation and corpus luteum formation, essential for pregnancy.
• Progesterone, produced by luteal cells, is critical for maintaining pregnancy.
• Hormone-sensitive lipase (HSL) and lipid droplets are vital for progesterone synthesis by providing cholesterol.

Purpose of the Study:

• To investigate the dynamic posttranslational modifications of HSL by protein kinase A (PKA) and AMP-activated protein kinase (AMPK).
• To determine the effects of these modifications on steroidogenesis in luteal cells.

Main Methods:

• Analysis of HSL phosphorylation at specific residues (Ser563, Ser565) mediated by PKA and AMPK.
• Measurement of progesterone production in response to LH/PKA and AMPK.
• Assessment of STAR, CYP11A1, and HSD3B protein levels.
• Evaluation of the impact of exogenous cholesterol on AMPK's effects.

Main Results:

• AMPK inhibits LH/PKA-stimulated progesterone production without altering key steroidogenic protein levels.
• AMPK reduces progesterone synthesis by inhibiting HSL phosphorylation at Ser565.
• LH/PKA promotes progesterone synthesis by increasing HSL phosphorylation at Ser563 and decreasing it at Ser565.
• Exogenous cholesterol counteracts AMPK's inhibitory effects, indicating AMPK regulates cholesterol availability.

Conclusions:

• LH and AMPK exert opposing effects on HSL posttranslational modifications, influencing cholesterol availability for progesterone synthesis.
• AMPK acts as an acute inhibitor of steroidogenesis in luteal cells by modulating HSL activity.
• Understanding these regulatory mechanisms is crucial for reproductive health and potential therapeutic interventions.